First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors

HIGHLIGHTS

• who: Todd Bauer from the Department of Drug Development, Sarah Cannon Research Nashville, TN, USA Seoul National University College of Medicine and Seoul have published the Article: First-in-human phase 1/1b study to evaluate Sitravatinib in patients with advanced solid tumors, in the Journal: (JOURNAL) of August/14,/2014
• what: The authors report results for the first-in-human phase 1/1b study of sitravatinib, in patients with advanced solid tumors, including non-small cell lung cancer (NSCLC; clinicaltrials.gov identifier: NCT02219711) . collection for 3-7 days, depending on emerging PK information. This . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.